By Michael Lilly, MD, RPVI, RVT

The pandemic has accelerated an already rapid evolution in the use of point-of-care ultrasound (POCUS) across the healthcare industry. While COVID-19 sparked a surge in POCUS usage among emergency room and intensive care settings, the technology was already spreading across most clinical applications thanks to its noninvasive efficacy, speed, economics, and superb safety record. In 2020, the global POCUS devices market generated $2,186.8 million in revenue and is expected to experience a compound annual growth rate of 7.9% during the forecast period (2021–2030), according to P&S Intelligence.

[fusion_widget_area name=”avada-blog-sidebar” title_size=”” title_color=”” background_color=”” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” /]